
Stock exchange intimation
Stock Exchange Intimation
Filter:
04 May 2026 – OneSource Supports Second Generic Semaglutide Approval in Canada- Enables commercialisation for the first two entrants in the world’s second-largest semaglutide market
29 Apr 2026 – OneSource’s Partner Dr. Reddy’s Laboratories receives Health Canada Approval for Generic Semaglutide Injection
21 Apr 2026 – Orbicular’s Partner secures tentative U.S. ANDA approval for a generic version of Ozempic® (Semaglutide Injection), supported by OneSource as CDMO partner
17 Apr 2026 – Intimation of the renewal of EU GMP Certification for OneSource: Flagship Unit II Facility located in Bengaluru
Stay informed
Don’t miss out on the latest news, results and key updates from OneSource.